Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahir Karakas

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Atherosclerosis|July 7, 2018
Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohortChristoph Waldeyer, Fabian J Brunner, Julian Braetz, et al.
Journal of Periodontal Research|June 8, 2022
Cross-sectional analysis of the association of periodontitis with carotid intima media thickness and atherosclerotic plaque in the Hamburg City health studyRagna Lamprecht, David Leander Rimmele, Renate B Schnabel, et al.
European Journal of Heart Failure|November 27, 2024
New cardiovascular biomarkers in patients with advanced cancer - A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNPMarkus S Anker, Laura C Lück, Muhammad Shahzeb Khan, et al.
The Lancet. Respiratory Medicine|July 10, 2021
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists WorkshopMattia Arrigo, Susanna Price, David A Baran, et al.
JAMA Cardiology|October 31, 2019
Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) ConsortiumErsin Cavus, Mahir Karakas, Francisco M Ojeda, et al.
The Lancet. Respiratory Medicine|December 13, 2021
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trialMahir Karakas, Ibrahim Akin, Christoph Burdelski, et al.
JAMA Cardiology|July 21, 2016
Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour AlgorithmJohannes Tobias Neumann, Nils Arne Sörensen, Tjark Schwemer, et al.
Clinical Chemistry|December 2, 2016
Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin IJohannes Tobias Neumann, Nils Arne Sörensen, Francisco Ojeda, et al.
European Journal of Heart Failure|June 27, 2023
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaireMarkus S Anker, Sophia K Potthoff, Alessia Lena, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 13, 2025
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer PatientsPia Weinländer, Sara Hadzibegovic, Jan Porthun, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Atherosclerosis|July 7, 2018
Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohortChristoph Waldeyer, Fabian J Brunner, Julian Braetz, et al.
Journal of Periodontal Research|June 8, 2022
Cross-sectional analysis of the association of periodontitis with carotid intima media thickness and atherosclerotic plaque in the Hamburg City health studyRagna Lamprecht, David Leander Rimmele, Renate B Schnabel, et al.
European Journal of Heart Failure|November 27, 2024
New cardiovascular biomarkers in patients with advanced cancer - A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNPMarkus S Anker, Laura C Lück, Muhammad Shahzeb Khan, et al.
The Lancet. Respiratory Medicine|July 10, 2021
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists WorkshopMattia Arrigo, Susanna Price, David A Baran, et al.
JAMA Cardiology|October 31, 2019
Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) ConsortiumErsin Cavus, Mahir Karakas, Francisco M Ojeda, et al.
The Lancet. Respiratory Medicine|December 13, 2021
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trialMahir Karakas, Ibrahim Akin, Christoph Burdelski, et al.
JAMA Cardiology|July 21, 2016
Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour AlgorithmJohannes Tobias Neumann, Nils Arne Sörensen, Tjark Schwemer, et al.
Clinical Chemistry|December 2, 2016
Immediate Rule-Out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin IJohannes Tobias Neumann, Nils Arne Sörensen, Francisco Ojeda, et al.
European Journal of Heart Failure|June 27, 2023
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaireMarkus S Anker, Sophia K Potthoff, Alessia Lena, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 13, 2025
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer PatientsPia Weinländer, Sara Hadzibegovic, Jan Porthun, et al.
Pageof 12